Patents by Inventor Gregory Dolganov

Gregory Dolganov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseases
    Patent number: 11572588
    Abstract: The present invention provides novel markers of treatment response in a subject infected with Mycobacterium, which allow for quantifying treatment impact on the physiologic state of the Mycobacterium.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: February 7, 2023
    Assignees: The Regents of the University of Colorado, a body corporate, The Regents of the University of California, Yale University, Colorado State University Research Foundation, The Board of Trustees of the Leland Standford Junior University
    Inventors: Nicholas D. Walter, Martin Voskuil, Gary Schoolnik, Gregory Dolganov, J. Lucian Davis, Payam Nahid, Greg Robertson, Anne Lenaerts
  • Methods of Evaluating Treatment Efficacy and/or Treatment Duration in Mycobacterial Diseases
    Publication number: 20200248259
    Abstract: The present invention provides novel markers of treatment response in a subject infected with Mycobacterium, which allow for quantifying treatment impact on the physiologic state of the Mycobacterium.
    Type: Application
    Filed: July 19, 2018
    Publication date: August 6, 2020
    Inventors: Nicholas D. Walter, Martin Voskuil, Gary Schoolnik, Gregory Dolganov, Lucian J. Davis, Payam Nahid, Greg Roberston, Anne Lenaerts
  • Transcripts encoding immunomodulatory polypeptides
    Publication number: 20030170714
    Abstract: Substantially-isolated polynucleotides encoding human polypeptides having immunomodulatory activity; human homologs of yeast RAD50, Drosophila Septin-2 and rat Acyl-CoA Synthetase compositions and methods; method for detecting the presence of activated T-cells.
    Type: Application
    Filed: March 19, 2003
    Publication date: September 11, 2003
    Applicant: Genelabs Technologies, Inc.
    Inventor: Gregory Dolganov
  • Transcripts encoding immunomodulatory polypeptides
    Patent number: 6555666
    Abstract: Substantially-isolated polynucleotides encoding human polypeptides having immunomodulatory activity; human homologs of yeast RAD50, Drosophila Septin-2 and rat Acyl-CoA Synthetase compositions and methods; method for detecting the presence of activated T-cells.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: April 29, 2003
    Inventor: Gregory Dolganov
  • Human RAD50 gene and methods of use thereof
    Patent number: 5965427
    Abstract: Substantially-isolated polynucleotides encoding human RAD50 polypeptides, human RAD50 genomic sequences, and methods of use thereof.
    Type: Grant
    Filed: July 17, 1996
    Date of Patent: October 12, 1999
    Assignee: Genelabs Technologies, Inc.
    Inventors: Gregory Dolganov, Alexander Novikov
  • Method of identifying activated T-cells
    Patent number: 5821091
    Abstract: A method of identifying the presence of activated T-cells in a sample containing a plurality of different cell types is disclosed. The method includes the detection of polynucleotide sequences selectively expressed in activated T-cells.
    Type: Grant
    Filed: January 26, 1996
    Date of Patent: October 13, 1998
    Assignee: Genelabs Technologies, Inc.
    Inventor: Gregory Dolganov